Stephanie Griffin
Obstetrics & Gynecology · Fort Payne, ALNPI 1497841977
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,147 of the $1,336 with a category attached, or 85.9%. 24 manufacturers reported payments, led by Astellas Pharma US Inc at 24.0% of the total. That places this record below the midpoint for obstetrics & gynecology clinicians in AL, where the typical reported total is $1,456.
Across 69 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$321
- Novo Nordisk$169
- Sumitomo Pharma America, Inc.$128
- Shield Therapeutics Inc$111
- Mayne Pharma Commercial LLC$86
- Takeda Pharmaceuticals U.S.A., Inc.$85
- plus $436 from 18 others
What the payments were for
- Food & beverage$1,14786%
- Education$18914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $321 |
| Novo Nordisk | 11 | $169 |
| Sumitomo Pharma America, Inc. | 6 | $128 |
| Shield Therapeutics Inc | 5 | $111 |
| Mayne Pharma Commercial LLC | 10 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Lilly USA, LLC | 3 | $48 |
| Medtronic | 3 | $43 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Mylan Specialty L.p. | 2 | $36 |
| Bayer | 2 | $30 |
| AbbVie | 2 | $30 |
| Amgen | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Scynexis, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| BD | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$1,336 in reported general payments places this provider in the 45th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 56 | $2,547 |
| Metronidazole | 12 | $333 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $224 |
| Sertraline Hcl | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Payne
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Praful PatelDothan$65K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- Francois BlaudeauHomewood$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.